Oncomfort offers an innovative Digital Sedation™ therapy, presenting a breakthrough in the healthcare industry by providing a drug-free solution to alleviate anxiety and pain associated with medical procedures. Employing a unique blend of clinical hypnosis and integrative therapeutic techniques through Virtual Reality, the company targets a significant need within the Health Care and VR/AR sectors.
Founded in 2017 and headquartered in Belgium, Oncomfort has gained substantial traction, indicated by their successful Series A funding round completed on 09 September 2020, amounting to €10.00M. The investment was backed by notable supporters such as Crédit Mutuel Innovation, Debiopharm Innovation Fund, and WING by Digital Wallonia. This injection of capital aligns with the strategic vision to advance non-pharmacological therapeutic solutions and foster growth potential in global markets.